1014707

Fresenius Kabi USA, LLC — FEI 3001833549

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 30, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Island, NY (United States)